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Abstract 
Review on t(1;20)(q10-21;q11-13), with data on 
clinics. 
Clinics and pathology 
Disease 
Acute myeloid leukemia (AML), acute 
lymphoblastic leukemia (ALL), myeloproliferative 
neoplasm (MPN), Myelodysplastic syndrome 
(MDS), multiple myeloma  (MM),  Burkitt 
lymphomas and non-Burkitt type lymphomas. 
Phenotype/cell stem origin 
Suggested involvement of a pluripotent stem cell. 
Epidemiology 
Rare karyotypic event in various hematologic 
malignancies; AML/MDS (5 cases), ALL (4 cases), 
MPN (2 cases), MM (4 cases), lymphoma (4 cases). 
Male predominance (15 males/ 3 females);  patients 
ages ranged from 1 to 73 years; described mainly in 
adults (aged 28 to 73 years); all the 4 ALL patients 
were children (aged 1 to 7 years) (Table 1).  
Prognosis 
Seems to confer a poor prognosis. 
Sex Age Karyotype Diagnosis Reference 
1 M 49 46,XY,t(3;11)(p13;q21)/46,XY,der(20)t(1;20)(q21;q13) biclonal clones PV Wan et al; 
2001 






Alter et al; 
2000 
3 M 38 47,XY,+?der(1)t(1;20)(q21;q11)del(1)(p11),-9,t(9;22)(q34;q11),+18,der(20)t 
(1;20)(q21;q11) 
CML Mori et al; 
1997 
4 M 30 46,XY,t(11;12)(q13;p13)/46,idem,der(9)t(1;9)(q12;p24)/ 
46,idem,der(14)t(1;14)(q12;p10)/ 
46,idem,der(20)t(1;20)(q12;q13)/46,idem,der(21)t(1;21) (q12;q10) 
AML-M5 Itzhar et 
al; 2011 
5 F 46,XX,der(20)t(1;20)(q21;q13) AML Raimondi 
et al;1999 
6 M 34 47,XY,t(9;22)(q34;q11),t(10;21)(p11;q22),der(20)t(1;20)(q21;q13),+der(22)t 
(9;22)/48,idem,+8 
AML-M1 Sasaki et 
al; 1983 




et al; 1999 
8 M 56,XY,+X,+Y,+5,+6,i(7)(q10),+9,+10,+11,+18,der(20)t(1;20)(q12;q13),+21,+22 ALL Hereema 
et al; 2004 
9 F 1 46,XX,t(4;11)(q21;q23),der(20)t(1;20)(q11;q13) ALL Prigogina 
et al; 1998 
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10 M 4 45,X,-Y,der(20)t(1;20)(q21;q13) B-ALL Raimondi 
et al; 2003 
11 M 59 47,XY,der(16)t(1;16)(q21;q11),+der(19)t(1;19)(q21;q13),der(20)t(1;20) 
(q21;q11) 
MM Keung et 
al; 1999 




et al; 2007 
13 M 54 54,XY,+3,+5,+9,+9,+15,+15,del(18)(q22),+19,der(20)t(1;20)(q21;q13),+21 MM Mohamed 
et al; 2007 
14 M  51-54,XY,+1,der(1;16)(q10;p10),+3,t(4;18)(p14;p11),del(6)(q25),del(6)(q23), 
+del(6)(q11),+7,+9,add(11)(q23),-13,+15,+18,der(20)t(1;20)(q12;q13),+mar 
MM Sawyer et 
al; 1998 
15 F 28 46,XX,t(14;18)(q32;q21)/47,idem,+12/47,idem,t(5;7)(q22;q32),+12/47,idem,+12, 
der(20)t(1;20)(q21;q13) lymph node 
FL B-cell Horsman 
et al; 2001 
16 M 2 47,XY,del(2)(q21q31),t(3;22)(q27;q11),del(6)(q13q15),der(8)t(2;8)(q21;q24), 
+11,der(20)t(1;20)(q21;q13) lymph node 
DLBCL Itoyama et 
al; 2002 
17 M 73 46,XY,i(6)(p10),t(8;14)(q24;q32),der(20)t(1;20)(q21;q13) lymph node BL Lones et 
al; 2004 
18 M  48,Y,t(X;1)(q28;p22),+Y,t(5;12;16)(p14;q24;p13),der(6)t(6;18)(q13;q21),-8, 
del(8)(p21),+add(9)(q22),add(12)(p11),der(18)t(8;18)(q11;q21),der(19)t(12;19) 




et al; 1999 
Abbreviations: PV, Polycythemia  vera; MDS, myelodysplastic syndrome; CML, Chronic myeloid leukemia; ALL,  acute 





Cytogenetically heterogeneous, the breakpoints in 
1q varied from 1q10 to 1q21, with a clustering to 
1q21, and the 20q breaks occurred in 20q10 to 
20q13, mainly in the 20q13 region. 
  
Partial karyotypes showing the unbalanced t(20)t(q10;q11). 
Additional anomalies 
Usually present with additional chromosomal  
abnormalities;  may be found together with well-
known primary abnormalities such as 
t(9;22)(q34;q11), t(4;11)(q21;q23), and 
t(14;18)(q32;q21), t(8;14)(q24;q32). 
 




Unbalanced translocations involving all or part of 
the long arms of chromosomes 1 and 20 are found in 
both hematologic neoplasms and lymphomas. The 
abnormality is usually present with complex pattern 
of rearrangements or occurring in a subclone; 
indicating that der(20)t(1;20) might be a secondary 
aberration. The extra copy of 1q segment and/ or 20q 
monosome may directly or indirectly provide a 
proliferative advantage leading to clonal evolution 
associated with tumor progression and advanced 
disease. 
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